Tenofovir Alafenamide Hemifumarate TAF CAS 1392275-56-7 API Factory Anti-HIV High Quality

Name: Tenofovir Alafenamide Hemifumarate (TAF) CAS: 1392275-56-7 White to Almost White Crystals or Crystalline Powder Assay: 98.0%~102.0% A prodrug for Tenofovir, used in combination therapy for the treatment of HIV-1 Infection High Quality, Commercial Production Inquiry: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Commercial Supply Tenofovir Related Intermediates: Tenofovir CAS: 147127-20-6 Tenofovir Disoproxil Fumarate CAS 202138-50-9 Tenofovir Alafenamide Hemifumarate CAS 1392275-56-7 Chloromethyl Isopropyl Carbonate CAS 35180-01-9 Diethyl (p-Toluenesulfonyloxymethyl)phosphonate CAS 31618-90-3 (R)-(+)-Propylene Carbonate CAS 16606-55-6 (R)-9-(2-Hydroxypropyl)adenine CAS 14047-28-0 Diethyl (Hydroxymethyl)phosphonate CAS 3084-40-0 Adenine CAS 73-24-5
Item Specifications
Appearance White to Almost White Crystals or Crystalline Powder
Solubility  Soluble in Dimethylformamide, and Methanol; Sparingly Soluble in Water and THF; Slightly Soluble in Acetonitrile and Insoluble in Dichloromethane and Toluene
Identification A The IR absorption spectra should be consistent with the reference 
Identification B The retention time of the major peak of the sample solution in the content determination chromatogram conforms to that of the reference solution
Identification C The Fumaric Acid retention time of the major peak in the content determination chromatogram conforms to the peak of the reference
Water Content (by K.F) ≤1.0%
Clarity of Solution Basically no visible particles in 2% (w/v) of the Methanol Solution clarification
Residual Solvent 
Acetonitrile  ≤410ppm
Ethanol ≤5000ppm
Dichloromethane ≤600ppm
Toluene ≤890ppm
Residue on Ignition ≤0.10% 
Heavy Metals ≤20ppm
Related Substances  
PMPA ≤1.0%
PMPA Anhydride ≤0.75%
Single Phenyl PMPA ≤1.0%
Any Unspecified  Impurity ≤0.15%
Total Impurities ≤2.0%
Isomer ≤1.0%
Content of Fumaric Acid 9.0%~13.0% (on the anhydrous basis )
Microbial Limits
Total Aerobic Microbial Count ≤1000CFU/g
Total Yeasts and Molds Count ≤100CFU/g
Escherichia Coli Absent
Assay  98.0%~102.0% (on the anhydrous and solvent-free basis )
Test Standard Enterprise Standard

Description:

Specifications:

Package & Storage:

Chemical Name Tenofovir Alafenamide Hemifumarate
Synonyms TAF; GS-7340 Hemifumarate
CAS Number 1392275-56-7
CAT Number RF-API91
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C25H33N6O9P
Molecular Weight 592.55
Storage Temperature Sealed in Dry, Room Temperature
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

Tenofovir Alafenamide Hemifumarate (TAF, GS-7340 hemifumarate), CAS 1392275-56-7,  is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of Tenofovir (TFV). By blocking reverse transcriptase, TAF prevent HIV from multiplying and can reduce the amount of HIV in the body. Tenofovir alafenamide is a prodrug, which means that it is an inactive drug. In the body, tenofovir alafenamide is converted to Tenofovir diphosphate (TFV-DP). Tenofovir Alafenamide Fumarate was approved in November 2015 for treatment of HIV-1.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours